{"id":"https://openalex.org/W2363886953","doi":null,"title":"A study in the female first-episode schizophrenia treated with Aripiprazole and Quetiapine","display_name":"A study in the female first-episode schizophrenia treated with Aripiprazole and Quetiapine","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2363886953","mag":"2363886953"},"language":"en","primary_location":{"id":"mag:2363886953","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTotal-ZMYX201005006.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764397312","display_name":"Medical Journal of Chinese People's Health","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361730560","host_organization_name":"China Association of Social Workers","host_organization_lineage":["https://openalex.org/P4361730560"],"host_organization_lineage_names":["China Association of Social Workers"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Medical Journal of Chinese People's Health","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019612999","display_name":"Han Shu-hua","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Han Shu-hua","raw_affiliation_strings":["Linyi No"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Linyi No","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5019612999"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.33215052,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/first-episode-schizophrenia","display_name":"first-episode schizophrenia","score":0.8769999742507935},{"id":"https://openalex.org/keywords/female-patients","display_name":"female patients","score":0.7929999828338623},{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":0.9900000095367432},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":1.0},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.8930000066757202},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.746999979019165},{"id":"https://openalex.org/keywords/sleepiness","display_name":"sleepiness","score":0.7120000123977661},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.8960000276565552},{"id":"https://openalex.org/keywords/amenorrhea-galactorrhea-syndrome","display_name":"amenorrhea-galactorrhea syndrome","score":0.8230000138282776},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.609000027179718},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.7799999713897705},{"id":"https://openalex.org/keywords/antipsychotic-safety","display_name":"antipsychotic safety","score":0.47600001096725464},{"id":"https://openalex.org/keywords/remission-rate","display_name":"remission rate","score":0.5889999866485596},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.4490000009536743}],"concepts":[{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.9539632797241211},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.8842439651489258},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6433544158935547},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5642175674438477},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5462212562561035},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5072442889213562},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4882960319519043},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.471090167760849},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.4488008916378021},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4445635974407196},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.443208783864975},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3930002748966217},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.37611567974090576},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.1684829294681549},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.052691102027893066},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2363886953","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTotal-ZMYX201005006.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764397312","display_name":"Medical Journal of Chinese People's Health","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361730560","host_organization_name":"China Association of Social Workers","host_organization_lineage":["https://openalex.org/P4361730560"],"host_organization_lineage_names":["China Association of Social Workers"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Medical Journal of Chinese People's Health","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2349845785","https://openalex.org/W2372009398","https://openalex.org/W1562262302","https://openalex.org/W2373268711","https://openalex.org/W2388367481","https://openalex.org/W2375608525","https://openalex.org/W2351656822","https://openalex.org/W2385256580","https://openalex.org/W2372471325","https://openalex.org/W3032818825"],"abstract_inverted_index":{"Objective:To":[0],"compare":[1],"efficacy":[2,76,110,289],"and":[3,7,40,57,65,77,82,107,121,147,174,193,245,270,290],"safety":[4,291],"of":[5,12,86,103,139,191,212,215,266,296,308],"Aripiprazole":[6,49,104,145,165,196,227,257],"Quetiapine":[8,51,124,152,169,203,220,262],"in":[9,33,97,123,144,151,164,168,195,202,219,226,274,294],"the":[10,27,36,84,108,132,185,264,282,305],"treatment":[11,265,295],"female":[13,91,267,297,309],"first-episode":[14,92,268,298,310],"schizophrenia.":[15,299],"Methods:The":[16],"randomized,double":[17],"blind,double":[18],"dummy":[19],"parallel":[20],"controlled":[21],"was":[22,105,112,119,127,142,149,171,180,198,222],"designed":[23],"for":[24,52,263],"this":[25,98],"study,All":[26],"cases":[28],"were":[29,46,72,95],"diagnosed":[30],"as":[31,259,261],"schizophrenia":[32,93,269,311],"accordance":[34],"with":[35,48],"CCMD-3":[37],"diagnosis":[38],"standard":[39],"randomized":[41],"into":[42],"two":[43,133,186,277],"groups":[44,134,187],"which":[45],"treated":[47],"or":[50,167,217,281],"8":[53,115],"weeks.":[54],"The":[55,100,136,160,189],"Positive":[56],"Negative":[58],"Syndrome":[59],"Scale":[60,70],"(PANSS),Clinical":[61],"Global":[62],"Impression":[63],"(CGI)":[64],"Treatment":[66],"Emergent":[67],"Side":[68],"effect":[69,141,162],"(TESS)":[71],"used":[73],"to":[74,303],"evaluate":[75],"adverse":[78,140,161],"effects":[79,273,285],"respectively":[80],"before":[81],"at":[83],"ends":[85],"2\u30014\u30018":[87],"weeks":[88,116],"treatment.Results:101":[89],"adult":[90],"patients":[94],"recruited":[96],"study.":[99],"remission":[101],"rates":[102],"38.0%":[106],"significant":[109,129,155,182],"rate":[111,138,190,211],"66.0%":[113],"after":[114],"while":[117],"that":[118,148,201,225,256],"35.3%":[120],"66.7%":[122],"group.":[125],"There":[126,179],"no":[128,181],"difference":[130,156,183],"between":[131,157,184],"(P0.05).":[135,159,188],"incidence":[137],"33.3%":[143],"group":[146,166,170,197,221],"35.2%":[150],"group,without":[153],"any":[154],"them":[158,275],"either":[163],"drowsiness":[172],"(14.8%vs19.6%),dizziness":[173],"faint":[175],"(11.1%":[176],"vs":[177,205,209,229,232],"12.9%).":[178],"nausea":[192],"vomiting,headache":[194],"higher":[199,223],"than":[200,224],"group(12.9%":[204],"1.9%,P0.05":[206,230],";":[207],"16.7%":[208],"1.9%,P0.01),The":[210],"dry":[213],"mouth,decrease":[214],"appetite":[216],"anorexia":[218],"group(14.8%":[228],";14.8%":[231],"1.9%":[233],",P0.05).":[234],"Both":[235],"drugs":[236,278,293],"showed":[237],"low":[238],"extrapyramidal":[239],"symptoms,less":[240],"endocrine":[241],"change,less":[242],"weight":[243],"gain":[244],"have":[246,279],"not":[247],"found":[248],"amenorrhea":[249],"galactorrhea":[250],"syndrome":[251],"during":[252],"treatment.Conclusions:The":[253],"results":[254],"suggest":[255],"is":[258],"effective":[260],"fewer":[271],"side":[272,284],",Although":[276],"different":[280],"same":[283],"profile,They":[286],"both":[287],"are":[288,301],"antipsychotic":[292],"They":[300],"beneficial":[302],"improve":[304],"therapeutic":[306],"compliance":[307],"patients.":[312]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
